Masaru Matsuda, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 1,434 shares at $15.82 ($23K) on 2023-03-02, disclosed to the SEC on 2023-03-06.
Scheduled sale ($23k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.82 | 1,416 | $22K | 98.7% |
| 2 | $16.52 | 18 | $297 | 1.3% |
| Total | $15.83 avg | 1,434 | $23K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $32K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $192K | — | Filing → |
| ARQT | SELL | 2026-03-03 | $314K | — | Filing → |